Victoria D. Turubanova
23 Gagarin Ave
Velikiy Novgorod, NGR 603022, Russian Federation
Velikiy Novgorod, NGR 603022, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Towards a personalized perspective on gliomas: an epigenetic-immuno-inflammatory aging framework.
Journal: Frontiers in immunology
Published: June 02, 2026
Ferroptosis with Contributions from Apoptosis and Necroptosis in Porphyrazine III-Based Photodynamic Therapy of Primary Human Gliomas.
Journal: Pharmaceutics
Published: April 15, 2026
Photo- and Immunotherapy Interface: Can Dendritic Cell Vaccines Overcome the Limitations of PDT?
Journal: Pharmaceutics
Published: April 09, 2026
From Data to Decision: Integrating Bioinformatics into Glioma Patient Stratification and Immunotherapy Selection.
Journal: International journal of molecular sciences
Published: November 23, 2025
Explainable Machine Learning Models for Glioma Subtype Classification and Survival Prediction.
Journal: Cancers
Published: June 24, 2025
Dendritic cell-derived exosomes as anti-cancer cell-free agents: new insights into enhancing immunogenic effects.
Journal: Frontiers in immunology
Published: March 03, 2025
Ferroptosis-armed dendritic cell vaccines for glioma immunotherapy.
Journal: Nature communications
Published: January 27, 2025
Gold standard assessment of immunogenic cell death induced by photodynamic therapy: From in vitro to tumor mouse models and anti-cancer vaccination strategies.
Journal: Methods in cell biology
Published: March 28, 2024
Unexplained Causes of Glioma-Associated Epilepsies: A Review of Theories and an Area for Research.
Journal: Cancers
Published: October 19, 2023
Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy.
Journal: Frontiers in immunology
Published: September 22, 2023
Targeting immunogenic cell death for glioma immunotherapy.
Journal: Trends in cancer
Published: September 06, 2023
Dendritic Cells Pulsed with Tumor Lysates Induced by Tetracyanotetra(aryl)porphyrazines-Based Photodynamic Therapy Effectively Trigger Anti-Tumor Immunity in an Orthotopic Mouse Glioma Model.
Journal: Pharmaceutics
Published: September 01, 2023
Last Updated: 09/26/2026